Noble Diagnostics Private Limited
About Noble Diagnostics Private Limited
Data last updated:
Noble Diagnostics Private Limited is a private limited company based in Chetpet, Tamil Nadu, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 22 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U73200TN2019PTC127659.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.15 Cr. It is led by directors Iravatham Sivamani Ramesh and Sureddi Jhansi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Krm Centre 9th Floor No.2 Harrington, Chetpet, Tamil Nadu, India – 600031.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.32 Cr, a growth of 80% compared to the previous year. For the same year it recorded a net loss of ₹41.73 Lakh (net margin -7.8%) and EBITDA of ₹8.91 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 77% over three years.
The company has about 31 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressKrm Centre 9th Floor No.2 Harrington, Chetpet, Tamil Nadu, India – 600031
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Noble Diagnostics Private Limited
The main business activity of Noble Diagnostics is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Noble Diagnostics Private Limited FY 2024 filings available
Noble Diagnostics Private Limited reported revenue of ₹5.32 Cr (up 80% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Noble Diagnostics Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 77% over three years, including 80% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Noble Diagnostics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹8.91 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹41.73 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Noble Diagnostics Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -7.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Noble Diagnostics are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Noble Diagnostics Private Limited
Noble Diagnostics Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| City Mri Centre Private Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Health Fortune E Private Limited | •••• | •••• | •••• | •••• | - | Jaipur, Rajasthan, India |
| Invitro Specialitylab Private Limited | •••• | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Narcissus Medical Centre Private Limited | •••• | •••• | •••• | •••• | - | Hooghly, West Bengal, India |
| Heilen Cross Diagnostics Private Limited | •••• | •••• | •••• | •••• | - | Kolkata, West Bengal, India |
| Noble Diagnostics Private Limited this company | •••• | •••• | •••• | •••• | - | Chetpet, Tamil Nadu, India |
| KDPL Diagnostics (Patiala) Private Limited | •••• | •••• | •••• | •••• | - | Pune, Maharashtra, India |
| Gyd Diagnostics and Reference Laboratories Private Limited | •••• | •••• | •••• | •••• | 30 | Secunderabad, Telangana, India |
| Aran Diagnostic Imaging Private Limited | •••• | •••• | •••• | •••• | - | Coimbatore, Tamil Nadu, India |
| Nishkam Imaging Solutions Private Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Omega Scan Diagnostics Private Limited | •••• | •••• | •••• | •••• | - | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Noble Diagnostics by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Board of Directors of Noble Diagnostics Private Limited
Noble Diagnostics has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Iravatham Sivamani Ramesh | Director | 16 Nov 2020 | 5 Years 10 Months | Current |
| Sureddi Jhansi | Director | 01 Dec 2021 | 4 Years 10 Months | Current |
Charges & Borrowings of Noble Diagnostics Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Dec 2020 | Hdfc Bank Limited | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Noble Diagnostics Private Limited
Employment history and EPFO contributions of people linked to Noble Diagnostics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Noble Diagnostics Private Limited
Noble Diagnostics Private Limited has 6 board changes on record since 2020: 2 appointments and 4 cessations. The latest: Sureddi Jhansi was appointed as Director on 01 Dec 2021.
Credit Ratings, Litigation & Regulatory Alerts for Noble Diagnostics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Noble Diagnostics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Noble Diagnostics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Noble Diagnostics Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Noble Diagnostics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Noble Diagnostics Private Limited
Noble Diagnostics is an active private limited company based in Chetpet, Tamil Nadu, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 22 February 2019 (7+ years old) and is registered under CIN U73200TN2019PTC127659.
Noble Diagnostics reported revenue of ₹5.32 Cr for FY 2024 (up 80% YoY).
Noble Diagnostics has 2 current directors:
- Iravatham Sivamani Ramesh - Director
- Sureddi Jhansi - Director
Noble Diagnostics reported a net loss of ₹41.73 Lakh (net margin -7.8%) and EBITDA of ₹8.91 Lakh (EBITDA margin 1.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Noble Diagnostics is 77% over three years. In the latest year (FY 2024) revenue rose 80%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Noble Diagnostics is U73200TN2019PTC127659. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Noble Diagnostics was incorporated on 22 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Noble Diagnostics by revenue are City Mri Centre Private Limited, Health Fortune E Private Limited, Invitro Specialitylab Private Limited, Narcissus Medical Centre Private Limited, Heilen Cross Diagnostics Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Sureddi Jhansi was appointed as Director on 01 Dec 2021. Ajay Kumar Sakamuri ceased to be Additional Director on 31 Dec 2020. Iravatham Sivamani Ramesh ceased to be Additional Director on 31 Dec 2020. Noble Diagnostics has 6 board changes on record in total.
The registered office of Noble Diagnostics is at Krm Centre 9th Floor No.2 Harrington, Chetpet, Tamil Nadu, India – 600031.
Noble Diagnostics has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.15 Cr.